Ovarian Cancer News From Medical News Today Latest Health News and Medical News posted throughout the day, every day.
Nektar Announces Positive Phase 2 Clinical Data From First Stage Of NKTR-102 Study In Women With Platinum-Resistant Ovarian Cancer
Nektar Therapeutics (Nasdaq: NKTR) announced preliminary progression-free survival data from the first stage of a two-stage Phase 2 clinical study evaluating single-agent treatment with NKTR-102 in women with platinum-resistant ovarian cancer...
Gynecologic Oncology Group Notifies CTI That Continuation Of GOG-212 Pivotal Trial Of OPAXIO Maintenance Therapy In Ovarian Cancer Is A Priority
Cell Therapeutics, Inc. ("CTI") (Nasdaq and MTA: CTIC) announced that CTI received a statement on March 1, 2010 from the Gynecologic Oncology Group (GOG) leadership that the phase III GOG-212 clinical trial of CTI's OPAXIOâ„¢ used as maintenance therapy for ovarian cancer remains a high priority and enrollment will continue...
Study Finds Delay In Referrals For Older Women With Ovarian Cancer
A study of electronic patient records, funded by the Wellcome Trust, suggests that older women with suspected ovarian cancer may be referred by their GPs for investigation later than younger women...
Study Finds Delay In Referrals For Older Women With Ovarian Cancer
A study of electronic patient records, funded by the Wellcome Trust, suggests that older women with suspected ovarian cancer may be referred by their GPs for investigation later than younger women...
Friess Commits Up To $50,000 To Help TGen Fight Ovarian Cancer
Moved by the death of an employee's daughter, prominent international businessman and philanthropist Foster Friess will make a substantial contribution to fund ovarian cancer research at the Translational Genomics Research Institute (TGen)...
Molecular Imaging Technique Uses Ultrasound And Microscopic Bubbles To Target Cancer Cells
An imaging technique combining ultrasound and specially modified contrast agents may allow researchers to noninvasively detect cancer and show its progression, according to research published in the March issue of The Journal of Nuclear Medicine (JNM). The technique enables researchers to visualize tumor activity at the molecular level...
Dietary Factors Influence Ovarian Cancer Survival Rates: New Study Shows Relationship Between Healthy Eating And Prolonged Survival
2009 estimates projected that in the United States alone 21,550 new cases of ovarian cancer would be diagnosed and 14,600 women would die of the disease. Often diagnosed in late stages, ovarian cancer has an asymptomatic onset and a relatively low 5-year survival rate of about 45%. Consequently investigation linked to survivorship is critical...
Side Effects And Drug Resistance Associated With Chemotherapy Tackled By Nanotechnology
Huixin He, associate professor of nanoscale chemistry at Rutgers University, Newark, and Tamara Minko, professor at the Rutgers Ernest Mario School of Pharmacy, have developed a nanotechnology approach that could potentially eliminate the problems of side effects and drug resistance in the treatment of cancer...
Chemosensitivity/Resistance Assay Included As Part Of The NCCN Principles Of Chemotherapy
Precision Therapeutics announced that The National Comprehensive Cancer Network® (NCCN®) recently updated the NCCN Clinical Practice Guidelines for Oncology (NCCN Guidelines™) for Ovarian Cancer Including Fallopian Tube Cancer and Primary Peritoneal Cancer to include the use of chemosensitivity/resistance assays as part of the Principles of Chemotherapy section...
Avastin Phase III Study Shows Positive Results In Women With Advanced Ovarian Cancer
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that a phase III study showed the combination of Avastin (bevacizumab) and chemotherapy followed by maintenance use of Avastin increased the time women with advanced ovarian cancer lived without their disease worsening (progression-free survival or PFS) compared to chemotherapy alone...
Fellowship Winners Make Cancer Their Focus
Two outstanding female scientists at the Walter and Eliza Hall Institute have been awarded research fellowships worth AU$1.75 million (US$1.5 million) to continue their cancer research...
Genentech Announces Positive Results Of Avastin Phase III Study In Women With Advanced Ovarian Cancer
Genentech, Inc...
Patient/Physician Team Walks You Through The Genetics, Diagnosis And Treatment If At High Risk For Breast Or Ovarian Cancer
When she was forty-two, Joi Morris learned that she has a genetic mutation on a gene known as BRCA2. This meant that her risk of getting breast cancer could be as high as 84 percent by age seventy, and that her risk for ovarian cancer was also high. Compounding her risk was the fact that her mother had developed breast cancer in her forties...
A New Way To Kill Cancer Cells
Ovarian and breast cancer treatments being developed that mix a protein inhibitor and traditional anticancer drugs are showing signs of success, according to a new review for Faculty of 1000 Biology Reports...
Curis Announces Chugai's Exercise Of Japanese Development Rights For GDC-0449
Curis, Inc. (NASDAQ: CRIS), a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, announced that Chugai Pharmaceutical Co., Ltd. (TSE: 4519) has exercised its right of first refusal for the development and commercialization in Japan of GDC-0449, a Hedgehog pathway inhibitor, under an existing agreement with F...
Discovery Of Switch That Turns On The Spread Of Cancer
Reporting in Nature Cell Biology, researchers describe the discovery of a specific protein called disabled-2 (Dab2) that switches on the process that releases cancer cells from the original tumor and allows the cells to spread and develop into new tumors in other parts of the body...
Single Gene Mutation Induces Endometrial Cancer
A mutation in a single gene can cause endometrial cancer that is responsive to a specific drug therapy, researchers at UT Southwestern Medical Center have found in an animal study. The finding suggests that eventually it might be possible to screen women with endometrial cancer to see if they have that mutation and use the drug as targeted therapy, the researchers said...
Abbott Submits New Automated Ovarian Cancer Test For U.S. Approval
A new diagnostic tool physicians can use to monitor patients for the most common form of ovarian cancer may soon be available in the United States. Abbott's ARCHITECT HE4 assay uses a simple blood test to help in monitoring for the recurrence or progression of epithelial ovarian cancer. If approved, this important immunoassay would be the first automated HE4 test available in the United States...
Symptoms Poor Indicators Of Ovarian Cancer, Study Finds
Only about 1% of women who experience symptoms of ovarian cancer, such as persistent bloating or pelvic pain, actually have the cancer, according to a study published Thursday in the Journal of the National Cancer Institute, Reuters reports...
Symptoms Have Little Value For Early Detection Of Ovarian Cancer
Use of symptoms to trigger a medical evaluation for ovarian cancer does not appear to detect early-stage ovarian cancer earlier and would likely result in diagnosis in only 1 out of 100 women in the general population with such symptoms, according to an article published online January 28 in the Journal of the National Cancer Institute...
Disarming Specialized Stem Cells Might Combat Deadly Ovarian Cancer
Eliminating cancer stem cells (CSCs) within a tumor could hold the key to successful treatments for ovarian cancer, which has been notoriously difficult to detect and treat, according to new findings published this week in the journal Oncogene by Yale School of Medicine researchers...
Two Combination Treatment Regimens Added To Updated NCCN Guidelines For Ovarian Cancer
The National Comprehensive Cancer Network (NCCN) recently updated the NCCN Clinical Practice Guidelines for Oncologyâ„¢ for Ovarian Cancer to reflect the addition of two preferred combination regimens for a specific cohort of patients based on data from recent clinical research studies...
Arrayit Corporation's Proteomic Biomarkers Clear The Way For Pre-Symptomatic Detection Of Ovarian Cancer And Other Major Diseases
Arrayit Corporation (OTCBB: ARYC), a leading manufacturer of products and services for disease prevention, treatment and cure, announces that Arrayit's new proteomic biomarkers will allow doctors to provide patients with a true pre-symptomatic diagnosis for Ovarian Cancer...
Diagnosis Of Early-Stage Ovarian Cancer By Ultrasound Plus Proteomic Blood Analyses
Noninvasive contrast-enhanced ultrasound imaging, combined with proteomic analyses of blood samples may help physicians identify early-stage ovarian cancer and save the lives of many women, according to an article published in the February issue of the American Journal of Roentgenology. Proteomics is the study of proteins, particularly their structure and function...
Abbott Receives European Regulatory Approval For New Ovarian Cancer Diagnostic Test
A new diagnostic tool, which studies show can aid in determining the risk of whether a pelvic mass is benign or malignant, is now available in Europe. This simple blood test is expected to help in the assessment of epithelial ovarian cancer, the most lethal form of gynecological cancer...
Worlds Best Pharmacy
canadian meds shop
Why is your product so cheap? How do you ship orders? We accept : Visa, MasterCard, AmEx, Diners and JCB cards. |
